These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3146891)

  • 1. Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine.
    Nolen WA; van de Putte JJ; Dijken WA; Kamp JS; Blansjaar BA; Kramer HJ; Haffmans J
    Acta Psychiatr Scand; 1988 Dec; 78(6):676-83. PubMed ID: 3146891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranylcypromine in depression resistant to cyclic antidepressions.
    Nolen WA
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):155-8. PubMed ID: 2664883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-5HTP in depression resistant to re-uptake inhibitors. An open comparative study with tranylcypromine.
    Nolen WA; van de Putte JJ; Dijken WA; Kamp JS
    Br J Psychiatry; 1985 Jul; 147():16-22. PubMed ID: 3933601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine.
    Nolen WA; van de Putte JJ; Dijken WA; Kamp JS; Blansjaar BA; Kramer HJ; Haffmans J
    Acta Psychiatr Scand; 1988 Dec; 78(6):668-75. PubMed ID: 3146890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients.
    Schiwy W; Heath WR; Delini-Stula A
    J Neural Transm Suppl; 1989; 28():33-44. PubMed ID: 2677240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of nomifensine, maprotiline and imipramine in a double-blind study of patients with endogenous depression].
    Faltus F; Filip V; Karen P; Kolomazník M; Korínková V; Libiger J; Molcan J; Zapletálek M; Zizka V
    Cesk Psychiatr; 1986 Apr; 82(2):131-8. PubMed ID: 3524870
    [No Abstract]   [Full Text] [Related]  

  • 7. High dose tranylcypromine therapy for refractory depression.
    Amsterdam JD; Berwish NJ
    Pharmacopsychiatry; 1989 Jan; 22(1):21-5. PubMed ID: 2710808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.
    Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
    J Clin Psychiatry; 2004 Nov; 65(11):1505-10. PubMed ID: 15554763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomifensine and maprotiline in endogenous depression: comparative efficacy and side effects.
    Levin A
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():89-96. PubMed ID: 6752081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants.
    Nolen WA; Haffmans PM; Bouvy PF; Duivenvoorden HJ
    J Affect Disord; 1993 Jul; 28(3):189-97. PubMed ID: 8408980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression.
    Siegfried K; O'Connolly M
    Int Clin Psychopharmacol; 1986 Jul; 1(3):231-43. PubMed ID: 3549874
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenelzine treatment of melancholia.
    McGrath PJ; Stewart JW; Harrison W; Wager S; Quitkin FM
    J Clin Psychiatry; 1986 Aug; 47(8):420-2. PubMed ID: 3525522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined MAO-inhibitor and tri- (tetra) cyclic antidepressant treatment in therapy resistant depression.
    Schmauss M; Kapfhammer HP; Meyr P; Hoff P
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):523-32. PubMed ID: 3406429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brofaromine in treatment-resistant depressed patients--a comparative trial versus tranylcypromine.
    Volz HP; Faltus F; Magyar I; Möller HJ
    J Affect Disord; 1994 Mar; 30(3):209-17. PubMed ID: 8006247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
    Kasper S; Voll G; Vieira A; Kick H
    Pharmacopsychiatry; 1990 May; 23(3):135-42. PubMed ID: 2115680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind study of tranylcypromine treatment of major anergic depression.
    Himmelhoch JM; Fuchs CZ; Symons BJ
    J Nerv Ment Dis; 1982 Oct; 170(10):628-34. PubMed ID: 7050302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the antidepressant action of tryptophan, tryptophan/5-hydroxytryptophan combination and nomifensine.
    Quadbeck H; Lehmann E; Tegeler J
    Neuropsychobiology; 1984; 11(2):111-5. PubMed ID: 6384815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of lithium-tranylcypromine treatment in refractory depression.
    Price LH; Charney DS; Heninger GR
    Am J Psychiatry; 1985 May; 142(5):619-23. PubMed ID: 3920923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranylcypromine vs nortriptyline vs placebo in depressed outpatients: a controlled trial.
    White K; Razani J; Cadow B; Gelfand R; Palmer R; Simpson G; Sloane RB
    Psychopharmacology (Berl); 1984; 82(3):258-62. PubMed ID: 6425910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression.
    Ricken R; Ulrich S; Schlattmann P; Adli M
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):714-731. PubMed ID: 28579071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.